<?xml version="1.0" encoding="UTF-8"?>
<p id="Par14">Barcelona, in Catalonia, Spain, was chosen as the location for this study due to the high formal availability of harm reduction services both in and outside prisons. The city hosts 15 drug consumption rooms and a large network of needle and syringe programmes (NSPs), opioid agonist therapy (OAT) programmes and integrated psychosocial services for people who use drugs. Spain is one of just ten countries worldwide that provide needle and syringe programmes in prisons [
 <xref ref-type="bibr" rid="CR32">32</xref>]. This context allows a focus on the unique issues faced by women when accessing those services.
</p>
